Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 22Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lymphoma 5Vomiting 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Nausea 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1

Interventions

Aprepitant 7Ondansetron 5Palonosetron 3Granisetron 3Dexamethasone 3Cyclophosphamide 3Calcium Dobesilate 3Vincristine 2Rituximab 2Doxorubicin 2dexamethasone acetate 1dexamethasone 21-phosphate 1Yoga 1Tropisetron 1Sugars 1R-CHOP protocol 1Prochlorperazine 1Prednisone 1Prednisolone 1Music Therapy 1Metoclopramide 1Lorazepam 1Immunoenzyme Techniques 1Electroacupuncture 1Cyproheptadine 1Antiemetics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × R-CHOP protocol × Lymphoid × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡